Li, B. et al. 2018. Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. Journal of Pharmacy & Pharmaceutical Sciences. 21, 1 (Jun. 2018), 222–235. DOI:https://doi.org/10.18433/jpps29831.